Abstract
Studies in vertebrate neuromuscular synapses have revealed previously that ATP, via P2Y receptors, plays a critical role in regulating postsynaptic gene expressions. An equivalent regulatory role of ATP and its P2Y receptors would not necessarily be expected for the very different situation of the brain synapses, but we provide evidence here for a brain version of that role. In cultured cortical neurons, the expression of P2Y1 receptors increased sharply during neuronal differentiation. Those receptors were found mainly colocalized with the postsynaptic scaffold postsynaptic density protein 95 (PSD-95). This arises through a direct interaction of a PDZ domain of PSD-95 with the C-terminal PDZ-binding motif, D-T-S-L of the P2Y1 receptor, confirmed by the full suppression of the colocalization upon mutation of two amino acids therein. This interaction is effective in recruiting PSD-95 to the membrane. Specific activation of P2Y1 (G-protein-coupled) receptors induced the elevation of intracellular Ca2+ and activation of a mitogen-activated protein kinase/Raf-1 signaling cascade. This led to distinct up-regulation of the genes encoding acetylcholinesterase (AChET variant), choline acetyltransferase, and the N-methyl-d-aspartate receptor subunit NR2A. This was confirmed, in the example of AChE, to arise from P2Y1-dependent stimulation of a human ACHE gene promoter. That involved activation of the transcription factor Elk-1; mutagenesis of the ACHE promoter revealed that Elk-1 binding at its specific responsive elements in that promoter was induced by P2Y1 receptor activation. The combined findings reveal that ATP, via its P2Y1 receptor, can act trophically in brain neurons to regulate the gene expression of direct effectors of synaptic transmission.
Footnotes
↵
The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
This work was supported by the University Grants Committee [Grant AoE/B-15/01]; Research Grants Council of the Hong Kong SAR China [Grants HKUST 660409; 6237/04M; 6404/05M; 6419/06M; and 3/03C]; and the Wellcome Trust [Grant 081706].
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.110.066506.
-
ABBREVIATIONS:
- CNS
- central nervous system
- A3P5P
- adenosine-3′,5′-bisphosphate
- AChE
- acetylcholinesterase
- Ara-C
- cytosine arabinoside
- ChAT
- choline acetyltransferase
- DIV
- days in vitro
- ERK
- extracellular signal-regulated kinase
- GAPDH
- glyceraldehyde-3-phosphate dehydrogenase
- GFAP
- glial fibrillary acidic protein
- GFP
- green fluorescent protein
- GPCR
- G protein-coupled receptor
- HA
- hemagglutinin
- HBSS
- Hanks’ balanced salt solution
- HEK
- human embryonic kidney
- Luc
- luciferase
- mAChR
- muscarinic acetylcholine receptor
- MAP-2
- microtubule-associated protein 2
- 2-MeSADP
- 2- (methylthio)adenosine 5′-diphosphate
- NHERF-2
- Na+/H+ exchanger regulatory factor type 2
- NR2
- N-methyl-d-aspartate receptor 2A
- PCR
- polymerase chain reaction
- PKC
- protein kinase C
- PRiMA
- proline-rich membrane anchor
- PSD-95
- postsynaptic density protein 95
- P2Y1R
- P2Y1 receptor
- TPA
- 12-O-tetradecanoylphorbol-13-acetate
- TTX
- tetrodotoxin
- NMDA
- N-methyl-d-aspartate
- bp
- base pair
- Ex
- excitation
- Em
- emission
- E
- embryonic day
- P
- postnatal day
- MRS2179
- 2′-deoxy-N6-methyladenosine 3′,5′-bisphosphate tetrasodium salt.
- Received May 19, 2010.
- Accepted September 16, 2010.
- Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|